Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation

Critical Care Medicine

Volumn 32, Issue 3, 2004, Pages 632-637

  Chenaud, Catherine ^a   Merlani, Paolo G ^a   Roux Lombard, Pascale ^a   Burger, Danielle ^a   Harbarth, Stephan ^a   Luyasu, Samuel ^a   Graf, Jean Daniel ^a   Dayer, Jean Michel ^a   Ricou, Bara ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Apolipoprotein A I; Critically ill; Inflammation; Inhibitory activity; Interleukin; Lipid; Marker

Indexed keywords

ALBUMIN; AMYLOID A PROTEIN; APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; PROCALCITONIN; TRIACYLGLYCEROL;

ACUTE PANCREATITIS; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LABORATORY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPTIC SHOCK; SURGICAL PATIENT; UNIVERSITY HOSPITAL;

ADULT; AGED; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; FEMALE; HOSPITAL MORTALITY; HUMANS; IMMUNITY; INTENSIVE CARE UNITS; INTERLEUKINS; MALE; MIDDLE AGED; OBSERVATION; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SWITZERLAND; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 1542719622     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000114820.47460.0A     Document Type: Article

References (28)

1. Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26:S64-S74
2. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003; 29:530-538
3. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996; 24:163-172
4. Goldie AS, Fearon KC, Ross JA, et al: Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome: The Sepsis Intervention Group. JAMA 1995; 274:172-177
5. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study. JAMA 1995; 273:117-123
6. Alvarez C, Ramos A: Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986; 32:142-145
7. -/- mice. J Lipid Res 1999; 40:1090-1103
8. Gordon BR, Parker TS, Levine DM, et al: Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med 2001; 29: 1563-1568
9. Pruzanski W, Stefanski E, de Beer FC, et al: Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J Lipid Res 2000; 41:1035-1047
10. van Leeuwen HJ, Heezius EC, Dallinga GM, et al: Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003; 31: 1359-1366
11. Fahie-Wilson M, Mills R, Wilson K: HDL cholesterol and the acute phase reaction following myocardial infarction and acute pancreatitis. Clin Chim Acta 1987; 167:197-209
12. Fraunberger P, Pilz G, Cremer P, et al: Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock 1998; 10:359-363
13. Gordon BR, Parker TS, Levine DM, et al: Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia. Crit Care Med 1996; 24:584-589
14. Cabana VG, Gidding SS, Getz GS, et al: Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res 1997; 42: 651-655
15. Segrest JP, Li L, Anantharamaiah GM, et al: Structure and function of apolipoprotein A-I and high-density lipoprotein. Curr Opin Lipidol 2000; 11:105-115
16. Flegel WA, Baumstark MW, Weinstock C, et al: Prevention of endotoxin-induced monokine release by human low-and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 1993; 61:5140-5146
17. Hyka N, Dayer JM, Modoux C, et al: Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 2001; 97:2381-2389
18. Pajkrt D, Manten A, van der Poll T, et al: Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 1997; 90:1415-1424
19. Sampietro T, Bigazzi F, Dal Pino B, et al: Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: A proinflammatory condition? Circulation 2002; 105: 11-14
20. Pirro M, Siepi D, Lupattelli G, et al: Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias. Metabolism 2003; 52:432-436
21. Furlaneto CJ, Ribeiro FP, Hatanaka E, et al: Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids 2002; 37: 925-928
22. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
23. Pajkrt D, Doran JE, Koster F, et al: Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 1996; 184:1601-1608
24. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-454
25. Marhaug G, Harklau L, Olsen B, et al: Serum amyloid A protein in acute myocardial infarction. Acta Med Scand 1986; 220:303-306
26. Reinhart K, Karzai W, Meisner M: Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000; 26:1193-1200
27. Kudsk KA, Tolley EA, DeWitt RC, et al: Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr 2003; 27:1-9
28. Alberti C, Brun-Buisson C, Goodman SV, et al: Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003; 168:77-84